Solara Active Pharma Sciences Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Solara Active Pharma Sciences Limited generated cash of $1,088,700,000, which is less than the previous year. Cash used in financing activities reached the amount of -$1,056,500,000 last year. Net change in cash is therefore -$2,900,000.
Cash Flow
| 2018 | 492.23M | -854.68M | 677.37M |
|---|---|---|---|
| 2020 | 2.44B | -3.58B | 949.1M |
| 2021 | 1.55B | -1.06B | 924.9M |
| 2023 | 1.56B | -811.4M | -1.12B |
| 2024 | 1.08B | -35.1M | -1.05B |
SOLARA.NS Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|
Cash at beginning of period | 87.3M | 463.8M | 560.4M | 757.2M | 144.6M |
Operating activities | |||||
Net income | -4.88B | -448.1M | 2.21B | 1.14B | 1.97M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.03B | 1.11B | 1.08B | 941.6M | 367.09M |
Stock-based compensation expense | 6M | 500K | 51.4M | 56M | 0 |
| Deferred income tax benefit | 6M | 500K | 51.4M | 56M | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 1.78B | -528M | -2.57B | 678M | -391.82M |
Inventories | 130.8M | 173.2M | -152.4M | -657.9M | -269.39M |
Accounts payable | 73M | 389M | 966.7M | -280.5M | 444.18M |
Cash generated by operating activities | 1.08B | 1.56B | 1.55B | 2.44B | 492.23M |
Investing activities | |||||
Purchases Of Investments | 0 | -12.8M | 0 | -500M | 0 |
Investments In Property Plant And Equipment | -410.6M | -1.11B | -1.74B | -2.68B | -347.36M |
Acquisitions Net | 0 | -12.8M | -1M | -550.1M | -509M |
Cash generated by investing activities | -35.1M | -811.4M | -1.06B | -3.58B | -854.68M |
Financing activities | |||||
Common Stock Issued | 0 | 0 | 2.98B | 297.6M | 100K |
Payments for dividends | 0 | 0 | -197.3M | -156.2M | 0 |
Repurchases of common stock | 0 | 0 | -353.7M | 0 | 0 |
Repayments of term debt | -1.14B | -647.5M | -2.62B | 1.63B | 528.31M |
Cash used in financing activities | -1.05B | -1.12B | 924.9M | 949.1M | 677.37M |
Net Change In Cash | -2.9M | -376.5M | 1.41B | -196.8M | 314.92M |
Cash at end of period | 84.4M | 87.3M | 1.97B | 560.4M | 459.52M |
| Data source | Data source | Data source | Data source | Data source |